A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
Clinical trial NCT06812117 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06812117
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-24
- Primary completion
- 2026-07-24
- Enrollment
- 721
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.